Alert: This Telehealth Stock Is Now a Bargain

Telehealth stock CloudMD Software (TSXV:DOC) is now a bargain.

| More on:

CloudMD Software (TSXV:DOC), an underrated telehealth stock,  caught some attention in 2020. The stock more than tripled in value as it got swept up in the tech frenzy. However, the excitement has now faded away. DOC stock is down 53% from its all-time high in February. While the company is worth half as much, its underlying fundamentals are stronger than ever. 

Here’s why this telehealth stock could be a bargain opportunity for growth investors in the months ahead. 

CloudMD’s edge

CloudMD’s stock performance makes it clear that investors considered telehealth a “COVID trend.” In other words, they expect the demand for remote healthcare and virtual appointments to fade as the economy reopens and things normalize. 

But I disagree with this notion. Access to healthcare professionals via video and chat is simply too convenient. The digitization of medical attention is a long-term trend that was simply boosted by the pandemic, not defined by it. This means that CloudMD’s advantages in virtual diagnostics and consultations are poised to last forever with or without COVID-19.

A string of recent acquisitions, including that of VisionPros for $60 million, has positioned the company on a path to robust growth. CloudMD still looks like a key player in the digitization of the healthcare industry. That’s an opportunity worth several trillion dollars. 

Consequently, CloudMD Software should continue to grow its revenue at a triple-digit pace. There’s plenty of room to attract new users, enter new geographies and offer innovative services to enhance the experience. 

Valuation

In the most recent quarter, the telehealth company delivered $15.7 million in revenue with adjusted EBITDA at a negative $0.7 million. Its annualized revenue run rate stands at over $140 million. Meanwhile, the company’s market capitalization stands at $337 million. In other words, CloudMD stock is trading at a forward price-to-revenue ratio of 2.4. That makes it considerably undervalued. 

At $1.47 a share, CloudMD is relatively cheap for any investor looking to gain exposure on the tech side and healthcare side. At the current valuation, the forward price-to-earnings multiple of 102 looks affordable. 

Bottom line

Bargains in the tech sector are rare. Investors are simply too excited about the prospects of FinTech, crypto, electric vehicles, and e-commerce right now. However, telehealth seems like a different story. Investors may have tossed these stocks in the “COVID fad” basket. That could be an opportunity. 

Robust telehealth stocks like CloudMD are severely beaten down. The company is trading for less than half its value seen earlier this year. Meanwhile, revenue continues to expand at an astonishing pace. Right now, you can buy the stock for just two times annual revenue. That’s a bargain for long-term growth investors. Don’t miss out!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

OpenText stock has fallen in the last few years, but that could mean this top tech stock remains an undervalued…

Read more »

AI microchip
Tech Stocks

Celestica Stock: Buy, Sell, or Hold?

Celestica's stock price has rallied 950% in the last five years. Will the AI boom send it even higher in…

Read more »

data analyze research
Tech Stocks

2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024

Well Health Technologies is a cheap growth stock to buy for its record-breaking results, massive revenue growth, and profitability.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

4 Reasons to Buy Kinaxis Stock Like There’s No Tomorrow

Kinaxis stock has a strong past. But there is even more to look forward to from this top tech stock.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

The Future of AI: Best Canadian Stocks to Buy Now

Here are two of the best AI-focused stocks in Canada that you can consider adding to your portfolio before it’s…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Tech Stocks

2 TFSA Stocks to Buy Right Now With $7,000

Are you looking for growth stocks that can help you maximize the tax-free withdrawals of the TFSA? This article is…

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy Right Now for Less Than $1,000

Not all tech stocks are the risky investments that many think they are. Which is why we're focusing on the…

Read more »

An analyst uses a computer and dashboard for data business analysis and Data Management System with KPI and metrics connected to the database for technology finance, operations, sales, marketing, and artificial intelligence.
Tech Stocks

Where Will Open Text Stock Be in 5 Years?

OpenText stock is one of the few tech stocks that's been around for decades. But does it have what it…

Read more »